Physician profile
David Kull
NPI 1235523648
$4,024.41
in general payments reported to CMS, 2019-2025
13 companies · $698 in 2025
The $698 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,967 · 2022: $276 · 2023: $561 · 2024: $523 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,782.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,781.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,806.29 | 2021-2025 | Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $402.66 | 2021-2025 | Closurefast, Endurant Iis |
| Abbott Laboratories | $389.84 | 2023-2025 | Esprit, Jeti All In One Non-Sterile Kit, Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $310.09 | 2023-2025 | Gore Excluder Aaa Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Conformable Thoracic Endoprosthesis |
| Bard Peripheral Vascular, INC. | $303.38 | 2023-2025 | Rotarexs 6 F X 135 Cm, Lutonix Drug Coated Balloon, Lifestent Solo Vascular Stent |
| Silk Road Medical, INC. | $271.01 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cook Medical LLC | $156.36 | 2024 | Zilver Ptx |
| Penumbra, INC. | $149.17 | 2025 | Penumbra System |
| Terumo Medical Corporation | $132.00 | 2023 | Metacross Otw, R2p Misago, Glidesheath Slender |
| Polynovo North America LLC | $36.38 | 2024 | Novosorb Btm |
| Lemaitre Vascular, INC. | $30.57 | 2023-2024 | Artegraft Vascular Graft, Xenosure Biologic Patch |
| Heron Therapeutics, INC. | $18.74 | 2021 | |
| Amgen INC. | $17.92 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.